Cargando…
A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatment
Selective serotonin reuptake inhibitors (SSRIs) are reported to exacerbate symptoms of anxiety when treatment is initiated. These clinical findings have been extended to animal models wherein SSRIs also potentiate anxiety and fear learning, which depend on the amygdala. Yet, little is known about th...
Autores principales: | Ravinder, S, Burghardt, N S, Brodsky, R, Bauer, E P, Chattarji, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566718/ https://www.ncbi.nlm.nih.gov/pubmed/23321806 http://dx.doi.org/10.1038/tp.2012.137 |
Ejemplares similares
-
Cellular Correlates of Enhanced Anxiety Caused by Acute Treatment with the Selective Serotonin Reuptake Inhibitor Fluoxetine in Rats
por: Ravinder, Shilpa, et al.
Publicado: (2011) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015) -
Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala
por: Marcinkiewcz, Catherine A., et al.
Publicado: (2016) -
Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)